150 related articles for article (PubMed ID: 26493035)
1. A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration.
Warwick A; Gibson J; Sood R; Lotery A
Eye (Lond); 2016 Mar; 30(3):488-91. PubMed ID: 26493035
[TBL] [Abstract][Full Text] [Related]
2. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation at the N-terminal domain of the TIMP3 gene in Sorsby fundus dystrophy.
Schoenberger SD; Agarwal A
Retina; 2013 Feb; 33(2):429-35. PubMed ID: 23023527
[TBL] [Abstract][Full Text] [Related]
4. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
[TBL] [Abstract][Full Text] [Related]
5. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
[TBL] [Abstract][Full Text] [Related]
6. Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.
Isashiki Y; Tabata Y; Kamimura K; Ohba N
Jpn J Ophthalmol; 1999; 43(6):472-80. PubMed ID: 10672875
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green angiography in Sorsby's fundus dystrophy.
Lafaut BA; De Backer E; Kohno T; De Laey JJ; Meire FM
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):158-62. PubMed ID: 10766286
[TBL] [Abstract][Full Text] [Related]
8. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
Li Z; Clarke MP; Barker MD; McKie N
Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data.
Friberg TR; Bilonick RA; Brennen PM
Ophthalmology; 2012 Jul; 119(7):1432-7. PubMed ID: 22551740
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.
Cohen SY; Dubois L; Tadayoni R; Delahaye-Mazza C; Debibie C; Quentel G
Br J Ophthalmol; 2007 Mar; 91(3):354-9. PubMed ID: 16973663
[TBL] [Abstract][Full Text] [Related]
11. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
[TBL] [Abstract][Full Text] [Related]
13. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
Kim JH; Kim JR; Kang SW; Kim SJ; Ha HS
Am J Ophthalmol; 2013 Apr; 155(4):743-9, 749.e1-2. PubMed ID: 23317655
[TBL] [Abstract][Full Text] [Related]
14. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.
Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B
Cells; 2020 Mar; 9(3):. PubMed ID: 32143276
[TBL] [Abstract][Full Text] [Related]
15. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
16. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.
De La Paz MA; Pericak-Vance MA; Lennon F; Haines JL; Seddon JM
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1060-5. PubMed ID: 9152225
[TBL] [Abstract][Full Text] [Related]
17. Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.
Peters AL; Greenberg J
Retina; 1995; 15(6):480-5. PubMed ID: 8747441
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene.
Ayyagari R; Griesinger IB; Bingham E; Lark KK; Moroi SE; Sieving PA
Arch Ophthalmol; 2000 Jan; 118(1):85-92. PubMed ID: 10636420
[TBL] [Abstract][Full Text] [Related]
20. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
Shah VP; Shah SA; Mrejen S; Freund KB
Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
